UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031900
Receipt number R000036424
Scientific Title PlGF/sFlt-1 and outcomes in CKD
Date of disclosure of the study information 2018/03/27
Last modified on 2021/09/28 12:21:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

PlGF/sFlt-1 and outcomes in CKD

Acronym

PlGF/sFlt-1 and outcomes

Scientific Title

PlGF/sFlt-1 and outcomes in CKD

Scientific Title:Acronym

PlGF/sFlt-1 and outcomes

Region

Japan


Condition

Condition

CKD

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We shows PlGF/sFlt-1 as a useful predictor in CKD.

Basic objectives2

Others

Basic objectives -Others

We investigates whether PlGF/sFlt-1 is independently associated with cardiac and renal events in CKD patients.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

cardiovascuar events
renal outcomes including end staging renal disease
renal anemia
all-cause mortality
cancer incidence

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

CKD criteria defined as an eGFR less than 60 mL/min or continuous proteinuria over 3 months

Key exclusion criteria

acute coronary syndrome within 3 months
malignancy within 5 years
acute kidney injury
pregnancy

Target sample size

1351


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Matsui

Organization

Nara Medical University

Division name

Nephrology

Zip code

6348521

Address

840 Shijo-cho, Kashihara, Nara

TEL

0744-22-3051

Email

matsui-o-v2008420@olive.plala.or.jp


Public contact

Name of contact person

1st name Masaru
Middle name
Last name Matsui

Organization

Nara Medical University

Division name

Nephrology

Zip code

6248521

Address

840 Shijo-cho, Kashihara, Nara

TEL

0744-22-3051

Homepage URL


Email

matsui-o-v2008420@olive.plala.or.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University

Address

840 Shijo-cho, Kashihara

Tel

0744-22-3051

Email

matsui-o-v2008420@olive.plala.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2004 Year 04 Month 01 Day

Date of IRB

2005 Year 08 Month 24 Day

Anticipated trial start date

2004 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We are investigating the relation between PlGF/sFlt-1 and cardiac and renal events.


Management information

Registered date

2018 Year 03 Month 26 Day

Last modified on

2021 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036424


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name